Key facts
- Ubicept’s last known valuation is $43.0M (Jun 2025).
- It has raised $12.7M across 2 recorded rounds; the latest was Seed Round ($4.6M) in Jun 2025.
- Notable investors include Alumni Ventures, gBETA, E14 Fund, The Engine, Massachusetts Institute of Technology — 17 tracked in total.
- Ubicept has filed 2 Form Ds with the SEC since 2023, most recently Jun 2025 ($4.6M sold to 9 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for Ubicept
Funding rounds
2 roundsAbout Ubicept
Developer of image sensors designed for advanced computer vision algorithms to capture motion. The company offers advanced photon-level processing algorithms, sensor-agnostic integration, and a development kit with cameras to capture clear images in extreme lighting, high-motion, and around-corner scenarios, enabling industries like automotive and robotics to achieve reliable perception in challenging environments.
- Sector
- Information Technology
- HQ
- Boston, MA, United States
- Founded
- 2021
- Employees
- 16
- Website
- ubicept.com/
- Ownership
- Privately Held (backing)
Ubicept doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ubicept shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ubicept in its N-PORT filings yet. We sweep new filings monthly.